182 related articles for article (PubMed ID: 12712489)
21. [Results of Wilms' tumor trial (WT-99) in Shanghai children's medical center].
Tang JY; Pan C; Xu M; Xue HL; Chen J; Zhao HL; Gu LL; Wang YP
Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):131-4. PubMed ID: 14759320
[TBL] [Abstract][Full Text] [Related]
22. [Nephroblastomas (Wilms' tumors) and special variations of nephroblastomas].
Schmidt D
Veroff Pathol; 1989; 133():1-174. PubMed ID: 2556868
[TBL] [Abstract][Full Text] [Related]
23. A 23-year experience with malignant renal tumors in infancy and childhood.
Tröbs RB; Hänsel M; Friedrich T; Bennek J
Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
[TBL] [Abstract][Full Text] [Related]
24. Histological analysis of aggressiveness and responsiveness in Wilms' tumor.
Beckwith JB; Zuppan CE; Browning NG; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):422-8. PubMed ID: 8827069
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
Suita S; Kinoshita Y; Tajiri T; Hara T; Tsuneyoshi M; Mizote H; Inada H; Takamatsu H; Kawano Y; Inomata Y; Nagasaki A; Ono Y; Handa N; Okamura J; Ishii E; Kawakami K;
J Pediatr Surg; 2006 Sep; 41(9):1501-5. PubMed ID: 16952581
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
29. Management of bilateral Wilms tumor over three decades: The perspective of a single center.
User IR; Ekinci S; Kale G; Akyüz C; Büyükpamukçu M; Karnak I; Çiftçi AÖ; Tanyel FC; Şenocak ME
J Pediatr Urol; 2015 Jun; 11(3):118.e1-6. PubMed ID: 25842994
[TBL] [Abstract][Full Text] [Related]
30. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study.
Hamilton TE; Green DM; Perlman EJ; Argani P; Grundy P; Ritchey ML; Shamberger RC
J Pediatr Surg; 2006 Oct; 41(10):1641-4. PubMed ID: 17011261
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
Lahoti C; Thorner P; Malkin D; Yeger H
Am J Pathol; 1996 May; 148(5):1577-89. PubMed ID: 8623926
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Wilms' tumor in eastern China: 10 years of experience at a single center.
Yao W; Li K; Xiao X; Gao J; Dong K; Xiao X; Lv Z
J Invest Surg; 2012 Jun; 25(3):181-5. PubMed ID: 22583015
[TBL] [Abstract][Full Text] [Related]
33. TP53 codon 72 polymorphisms in favorable histology Wilms tumors.
Cost NG; Mitui M; Khokhar S; Wickiser JE; Baker LA; Rakheja D
Pediatr Blood Cancer; 2012 Aug; 59(2):326-8. PubMed ID: 22052810
[TBL] [Abstract][Full Text] [Related]
34. New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience.
Vujanić GM; Harms D; Sandstedt B; Weirich A; de Kraker J; Delemarre JF
Med Pediatr Oncol; 1999 May; 32(5):317-23. PubMed ID: 10219330
[TBL] [Abstract][Full Text] [Related]
35. The cytomorphologic spectrum of Wilms tumour on fine needle aspiration: a single institutional experience of 110 cases.
Nayak A; Iyer VK; Agarwala S
Cytopathology; 2011 Feb; 22(1):50-9. PubMed ID: 20236293
[TBL] [Abstract][Full Text] [Related]
36. p53 immunopositivity in histologically favorable Wilms tumor is not related to stage at presentation or to biological aggression.
D'Angelo MF; Kausik SJ; Sebo TJ; Rathbun SR; Kramer SA; Husmann DA
J Urol; 2003 May; 169(5):1815-7. PubMed ID: 12686851
[TBL] [Abstract][Full Text] [Related]
37. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.
Murphy AJ; Pierce J; de Caestecker C; Libes J; Neblett D; de Caestecker M; Perantoni AO; Tanigawa S; Anderson JR; Dome JS; Das A; Carroll TJ; Lovvorn HN
Pediatr Blood Cancer; 2014 Feb; 61(2):198-205. PubMed ID: 24115727
[TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemical expression of p53 oncoprotein in Wilms tumour in relation to histological components, histological types and preoperative chemotherapy].
Djuricić S; Djokić D; Vujić D; Basta-Jovanović G; Todorović V; Radojević-Skodrić S; Zdravković S; Vujanić GM
Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():298-306. PubMed ID: 20804099
[TBL] [Abstract][Full Text] [Related]
39. Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).
Mavinkurve-Groothuis AM; van den Heuvel-Eibrink MM; Tytgat GA; van Tinteren H; Vujanic G; Pritchard-Jones KL; Howell L; Graf N; Bergeron C; Acha T; Catania S; Spreafico F
Pediatr Blood Cancer; 2015 Apr; 62(4):598-602. PubMed ID: 25546733
[TBL] [Abstract][Full Text] [Related]
40. Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties.
Vujanić GM; Schiavo Lena M; Sebire NJ
Virchows Arch; 2019 Feb; 474(2):227-234. PubMed ID: 30515564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
